NCT06820203View on ClinicalTrials.gov

Premixed, Sequential and Manually Mixed Administration of Intrathecal Fentanyl and Bupivacaine in Cesarean Section

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 12, 2025

Primary Completion Date

July 15, 2025

Study Completion Date

July 15, 2025

Conditions
PremixedSequentialManually MixedIntrathecalFentanylBupivacaineCesarean Section
Interventions
DRUG

Fentanyl and Bupivacaine

Patients will receive premixed intrathecal fentanyl and bupivacaine in the same syringe.

DRUG

Fentanyl and Bupivacaine

Patients will receive intrathecal fentanyl and bupivacaine in separate syringes.

DRUG

Fentanyl and Bupivacaine

Patients will receive manually mixed intrathecal fentanyl and bupivacaine in the same syringe.

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06820203 - Premixed, Sequential and Manually Mixed Administration of Intrathecal Fentanyl and Bupivacaine in Cesarean Section | Biotech Hunter | Biotech Hunter